
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


Streamline Health Solutions Inc (STRM)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: STRM (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type Stock | Historic Profit -78.4% | Avg. Invested days 28 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.34M USD | Price to earnings Ratio - | 1Y Target Price 22.5 |
Price to earnings Ratio - | 1Y Target Price 22.5 | ||
Volume (30-day avg) 14983 | Beta 1.64 | 52 Weeks Range 1.85 - 9.75 | Updated Date 02/16/2025 |
52 Weeks Range 1.85 - 9.75 | Updated Date 02/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.35 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -92.72% | Operating Margin (TTM) -71.44% |
Management Effectiveness
Return on Assets (TTM) -10.54% | Return on Equity (TTM) -80.09% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 26891430 | Price to Sales(TTM) 0.83 |
Enterprise Value 26891430 | Price to Sales(TTM) 0.83 | ||
Enterprise Value to Revenue 1.45 | Enterprise Value to EBITDA -24.03 | Shares Outstanding 4273180 | Shares Floating 25943347 |
Shares Outstanding 4273180 | Shares Floating 25943347 | ||
Percent Insiders 24.22 | Percent Institutions 20.37 |
AI Summary
Streamline Health Solutions Inc. (STLH) Overview
Company Profile:
History and Background:
- Founded in 2001, Streamline Health Solutions Inc. (STLH) is a healthcare technology company focused on improving patient care and optimizing costs across the healthcare continuum.
- Initially specializing in point-of-care medication and inventory management software, STLH has expanded its offerings to include pharmacy management, clinical workflow solutions, and analytics.
- Headquartered in Nashville, Tennessee, STLH employs over 1000 people and serves over 5,000 healthcare facilities across the United States.
Core Business Areas:
- Medication Management Solutions: STLH offers a comprehensive suite of medication management solutions, including point-of-care medication and inventory management, automated dispensing cabinets, and medication reconciliation systems.
- Clinical Workflow Solutions: The company provides various solutions to streamline clinical workflows, such as patient tracking, electronic charting, and care coordination tools.
- Analytics and Data Management: STLH offers data aggregation and analytics solutions to help healthcare providers improve patient care and optimize resource utilization.
Leadership Team and Corporate Structure:
- President and CEO: Raj Ganguly, M.D.
- Executive Vice President and Chief Technology Officer: Mark Polzin
- Executive Vice President and Chief Sales Officer: Kevin Weinstein
- Chief Financial Officer: Steven P. Ridenour
- The company's corporate structure is comprised of various departments, including sales, marketing, product development, finance, and customer service.
Top Products and Market Share:
- Top Products: STLH's top products include Acuity, PharmacyOS, and CareCom. Acuity is a cloud-based medication management solution for hospitals and health systems. PharmacyOS is a pharmacy management platform that automates dispensing and inventory management tasks. CareCom is a patient care coordination platform that facilitates communication and collaboration between healthcare providers.
- Market Share: STLH holds a significant market share in the hospital pharmacy automation market, estimated at approximately 20%. The company's medication management solutions are used by leading healthcare providers across the United States.
- Product Performance and Market Reception: STLH's products have received positive reviews from users, who commend their ease of use, interoperability, and impact on patient safety and operational efficiency.
Total Addressable Market:
- The total addressable market (TAM) for STLH's solutions is estimated to be over $10 billion, encompassing hospitals, health systems, and other healthcare providers.
Financial Performance:
- Revenue: STLH's revenue in 2022 was $238.3 million, representing a 12% year-over-year increase.
- Net Income: The company's net income in 2022 was $17.4 million, compared to $12.1 million in 2021.
- Profit Margin: STLH's profit margin stands at 7.3%, indicating a healthy profitability level.
- Earnings per Share (EPS): The company's EPS in 2022 was $0.48, exceeding analyst expectations.
- Cash Flow and Balance Sheet: STLH has a strong cash flow position with $21.3 million in cash and equivalents as of December 31, 2022. The company's balance sheet is also healthy, with a low debt-to-equity ratio.
Dividends and Shareholder Returns:
- Dividend History: STLH does not currently pay dividends.
- Shareholder Returns: Over the past year, STLH's stock has generated a total return of 15%, outperforming the S&P 500 index.
Growth Trajectory:
- Historical Growth: STLH has experienced consistent revenue growth over the past five years, with an average annual growth rate of 10%.
- Future Growth Projections: Analysts expect STLH to maintain its growth momentum, with revenue projections of $300 million for 2024.
- Growth Initiatives: STLH is actively investing in product innovation and expanding its sales and marketing efforts to fuel future growth.
Market Dynamics:
- Industry Trends: The healthcare technology market is experiencing significant growth, driven by factors such as the aging population, increasing healthcare costs, and the adoption of electronic health records (EHRs).
- Demand-Supply Scenario: The demand for healthcare technology solutions is expected to continue to outpace supply, creating opportunities for companies like STLH.
- Technological Advancements: STLH is actively incorporating artificial intelligence (AI) and machine learning (ML) into its solutions to enhance functionality and improve patient outcomes.
Competitors:
About Streamline Health Solutions Inc
Exchange NASDAQ | Headquaters Alpharetta, GA, United States | ||
IPO Launch date 1996-04-18 | CEO & Director Mr. Benjamin L. Stilwill | ||
Sector Healthcare | Industry Health Information Services | Full time employees 77 | Website https://www.streamlinehealth.net |
Full time employees 77 | Website https://www.streamlinehealth.net |
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and accurately billed and reduce revenue leakage; and eValuator, a coding analysis platform that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team. It also provides Data Comparison Engine, a cloud-based SaaS system synchronization module that operates and automates the reconciliation of these systems to identify discrepancies or errors occurring between systems; CDI that provides an integrated on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables the seamless sharing of patient data; and Financial Management Solutions, which offers financial staff across the healthcare enterprise with actionable and real-time financial data and key performance indicators to improve revenue realization. In addition, the company provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.